Mattia Galli/LinkedIn
Oct 5, 2025, 08:21
Mattia Galli Gives a Talk on Pharma Pulse About “De-escalation” of Antiplatelet Therapy in ACS
Mattia Galli, Assistant Professor at Sapienza Università di Roma, Associate Editor of European Heart Journal, shared on LinkedIn:
”How far can we go with the “de-escalation” of antiplatelet therapy in patients with acute coronary syndrome?
We talk about it in our Pharma Pulse following the publication of the NEO-MINDSET trial.”
Read the full article in EHJ.
Article: Seeking for the boundaries of de-escalation in antiplatelet therapy for acute coronary syndrome
Authors: Mattia Galli, Felice Gragnano, Marco Valgimigli
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jan 8, 2026, 05:51Dominika Jędrzejewska Akbaş Links Sleep Deprivation, Obesity, and Stroke
-
Jan 8, 2026, 05:42Rob Maloney: A Bruise that Did Not Go Away…
-
Jan 8, 2026, 05:33Matías J Alet on Treating Early Neurological Deterioration in Lacunar Stroke
-
Jan 8, 2026, 05:11Thomas Meinel Shares The English Stroke Guidelines 2026
-
Jan 8, 2026, 05:03Hilla Ben-Pazi: We Were Pleased to Receive a Grant from the Israeli Ministry of Economy
-
Jan 8, 2026, 04:24Nikhil Agrawal Breaks Down Perioperative Anticoagulation
-
Jan 8, 2026, 03:58Louise St Germain Bannon Appointed Interim Executive Director of ISTH
-
Jan 8, 2026, 03:47Wolfgang Miesbach on Fernando Corrales-Medina’s Team’s Latest Cross-Sectional Study on Haemophilia
-
Jan 8, 2026, 03:28Rick Matthews: Powerful Perspective from Erin and the NBCA Team